| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dfab31402f484cf3b32ddfbc4bc1c5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4543ab34f35b8ef4c8d1b11a318123f6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0676 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-39 |
| filingDate |
2015-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_726f4bc862e6be57dea0ac779190a868
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d2d93ab293d484866f93b208a1c24c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8c4ba3cda3152d27a8edf9174d75850
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56c6f6e3f4302004d7f9515c97507ef1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70609c9870f1c587977d1bee549f5d52 |
| publicationDate |
2017-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017073642-A1 |
| titleOfInvention |
Methods of Obtaining Pancreatic Endocrine Cells |
| abstract |
The present invention relates to methods of producing pancreatic endocrine cells and uses of the cells obtained using the methods. The method utilises inhibitors or combinations of factors to provide increased quantities of endocrine material, for example for transplantation purposes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3635106-A4 |
| priorityDate |
2014-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |